Search | DIAL.pr - BOREAL

Accès à distance ? S'identifier sur le proxy UCLouvain

Displaying 2 results.

- Journal article
Phase 1 first-in-human trial of the anti-CD37 antibody BI 836826 in relapsed/refractory chronic lymphocytic leukemia.
Stilgenbauer, Stephan Aurran Schleinitz, Thérèse Eichhorst, Barbara Lang, Fabian Offner, Fritz Rossi, Jean-François Schroyens, Wilfried Van Den Neste, Eric[UCL] Ysebaert, Loïc von Wangenheim, Ute Ursula Kress, Uta Blum, Petra Zenz, Thorsten (2019) Leukemia — Vol. 33, no.10, p. 2531-2535 (2019)
- Journal article
R-CODOX-M/R-IVAC versus DA-EPOCH-R in patients with newly diagnosed Burkitt lymphoma (HOVON/SAKK): final results of a multicentre, phase 3, open-label, randomised trial.
Chamuleau, Martine E D Stenner, Frank Chitu, Dana A Novak, Urban Minnema, Monique C Geerts, Paul Stevens, Wendy B C Zenz, Thorsten van Imhoff, Gustaaf W Wu, Ka Lung Demandt, Astrid M P Kersten, Marie Jose Terpstra, Wim E Tick, Lidwine W Deeren, Dries Van Den Neste, Eric[UCL] Gregor, Michael Veelken, Hendrik Böhmer, Lara H Caspar, Clemens B Mutsaers, Pim Refos, Jeannine M Sewsaran, Robby Fu, Liping Seefat, Rianne L Uyl-de Groot, Carin A Dirnhofer, Stefan Van Den Brand, Michiel de Jong, Daphne Nijland, Marcel Lugtenburg, Pieternella (2023) The Lancet. Haematology — Vol. 10, no.12, p. e966-e975 (2023)